Get notified when PRGO files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Goodwill Impairment (worsened) — Company recorded $330.8M in goodwill impairments across three reporting units after a segment reorganization.
- Securities Litigation (new) — New securities class action filed in November 2025 alleging misstatements related to the infant formula business.
- Credit Rating Downgrade (worsened) — Moody's downgraded to Ba3 and S&P to B+, increasing borrowing costs.
- Operating Cash Flow Deterioration (worsened) — Operating cash flow swung from positive $11.4M to negative $31.0M in the six-month comparison.
Perrigo swings to $74.5M net income on non-operating factors as operating income falls 48%
Filed August 5, 2026 · Period ending June 27, 2026 · Compared to 10-Q Aug 6, 2025 · ~1 min read
Key Changes
-
high
Net income swung to $74.5M from a loss a year ago, but operating income fell 48% to $23.5M — the bottom-line gain did not come from operations.
MD&A: Results verify on EDGAR → -
high
Completed the Dermacosmetics divestiture for $362.9M, booking a $129.5M pre-tax gain and using proceeds to pay down debt.
MD&A: Divestiture verify on EDGAR → -
high
New securities class action filed in Nov 2025; acetaminophen appellate ruling vacates expert exclusions, reviving litigation risk.
Legal Proceedings verify on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (ESTC 10-Q) is open in full — no account needed.
Partner
Trade PRGO commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 1, 2026 · How we verify